+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nocturia

  • ID: 4806644
  • Book
  • 154 Pages
  • Elsevier Science and Technology
1 of 3

Nocturia: Etiology, Pathology, Risk Factors, Treatment and Emerging Therapy includes the background, prevalence, etiology, risk factors, adverse effects and morbidity, as well as current and emerging treatments related to nocturia. Often considered a normal part of aging, nocturia can often be overlooked as a risk factor associated with serious outcomes such as mortality, morbidity, negative economic implications and decreased quality of life. This book provides comprehensive information on all aspects of nocturia as well as how the emerging therapies can provide safe, effective and low-cost treatment.

This is an important reference for researchers, urologists and clinicians interested in improving diagnosis and treatment of nocturia.

  • Explores the high prevalence of nocturia, reflecting on it as a normal part of aging and a serious indicator of illnesses
  • Presents the etiology of Nocturia to better determine its life-threatening consequences
  • Illustrates the causes of Nocturia and how to address them
  • Outlines the consequences of the condition

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 3
1. Introduction and Background
2. Etiology, Pathology and Risk Factors
3. Epidemiology and Prevalence
4. Adverse Effects and Co-Morbidity
5. Diagnosis, Assessment and Examination
6. Management and Treatments
7. Emerging Novel Therapies
8. Summary and Conclusion
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Lee, King C.
Dr. King Lee, PhD is currently an adjunct professor at Quinnipiac University, teaching Advanced Pharmacology and related courses to doctoral students in nursing. Dr. King Lee has performed multiple research projects and clinical studies in pharmacology, including clinical studies investigating the characteristics and new drug treatment for nocturia in patients with severe nocturia (the topic of the current book). He has authored and co-authored over 55 peer-reviewed manuscripts (scientific and professional papers, and review articles) and over 45 scientific abstracts. He has also authored chapters of several books. He has been an invited speaker to multiple national and international professional conferences or scientific meetings.
Weiss, Jeffrey P.
Dr. Jeffrey Weiss, MD, FACS is Professor & Chair in the Dept of Urology at SUNY Downstate College of Medicine. He is ACGME Program Director at SUNY Downstate Urology where he serves as head of the Academic Executive Committee. He is Chief of Urology at the VA New York Harbor Healthcare System. Dr. Weiss is the primary author of over 300 peer reviewed scientific articles, abstracts and book chapters as well as co-author of 4 urological textbooks. He is a member the International Continence Society, the Society for Urodynamics and Female Urology and the Society of University Urologists. Dr. Weiss has been Governor for the American College of Surgeons for the NYC area as well as District II representative board member to the NY Section of the American Urological Association. He is currently engaged in research regarding the cause and treatment of nocturia, overactive bladder and prostate cancer.
Note: Product cover images may vary from those shown
Adroll
adroll